Pharma Pulse 1/28/25: Operational Efficiency for Clinical Trials, Challenges of PrEP Access & more

Operational Efficiency for Clinical Trials

In this video interview, Dipanwita Das, CEO & co-founder at Sorcero, highlights trial startup timelines and workforce development as key areas of focus for clinical operations professionals in 2025.

PBM Reform: The Challenges of PrEP Access

Carl Schmid, Executive Director, HIV+Hepatitis Policy Institute, Washington, D.C., spoke about copay accumulator programs and why they must stop. He sat down with Managed Healthcare Executive afterward and explained how HIV medications are involved and why cost sharing is supposed to be free for specific forms of PrEP - but isn’t.

Merck’s $8 Billion Cancer Vaccine Faces First US Jury Trial

Merck & Co. is facing its first jury trial over claims the company wrongfully marketed its lucrative Gardasil cancer vaccine as safe, the latest high-stakes litigation for the pharmaceutical giant.
Senior Care Partners (PACE) Advances Elderly Patient Safety with DoseMeRx

DoseMe announced that Senior Care Partners (PACE) has implemented DoseMeRx to modernize vancomycin dosing in alignment with Area Under the Curve (AUC) guidelines. This advancement ensures standardized, efficient dosing practices across its team of three pharmacists, who manage a patient population of 600 outpatients.

UpScriptHealth on LinkedIn

Our partnerships withe#pharmaceutical and #medicaldevice companies have been doubling YoY, and we expect exponential growth in 2025. In part 3 of our founder & CEO Peter Ax's interview with Miranda Schmalfuhs at Pharmaceutical Executive, he sheds light on why more pharmaceutical and medical device companies are seeking out direct-to-patient #telehealth solutions.

Have news you want us to share in Pharma Pulse? Reach out to Editor Miranda Schmalfuhs